GoAI
Get started
SL Science Holding Ltd logo

SL Science Holding Ltd

SLBT

NASDAQHealthcareBiotechnology

Open in GoAI

Previous close

$2.65

−$0.06 · -2.21%

Aug 21, 4:00 PM ET

SLBT company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

10

Overpriced

Momentum

17

Strong Down

Sentiment

50

Mixed

Risk resilience

37

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Horizon Space Acquisition II Corp. aims to achieve strategic business combinations with other companies. This objective can be fulfilled through various transactional structures, including mergers, exchanges of shares, acquisitions of assets, direct purchases of stock, recapitalizations, or other forms of corporate reorganization. The firm was founded in 2023 and maintains its headquarters in New York, New York.

Industry
Biotechnology
Sector
Healthcare
Headquarters
US
CEO
William Wang
Listed since
Feb 5, 2025
Employees
15

Market position

Day range

Current $2.65

52-week range

Current $2.65

Open
$2.7421
Previous close
$2.71
Volume
28.49K
0.04× average
Average volume
696.19K
Average daily volume
Market cap
1.49B USD
Beta
0.09
Market reference 1
50-day average
$3.9359
-32.67% below average
200-day average
$8.2033
-67.70% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
-1.05M USD
EV / EBITDA
0.28×
Earnings yield
0.00%
Free cash flow yield
0.00%

Profitability & efficiency

Return on equity
-167.25%
Return on assets
-135.59%
Return on invested capital
-153.66%

Financial health

Current ratio
3.05×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends110%6%-97%-201%Gross margin, FY2023: 83.96%Gross margin, FY2024: 57.46%Gross margin, FY2025: 35.27%Operating margin, FY2023: 11.02%Operating margin, FY2024: -35.56%Operating margin, FY2025: -174.65%Net margin, FY2023: 45.40%Net margin, FY2024: -35.42%Net margin, FY2025: -173.85%FY2023FY2024FY2025
Gross margin FY2023 83.96%. Gross margin FY2024 57.46%. Gross margin FY2025 35.27%. Operating margin FY2023 11.02%. Operating margin FY2024 -35.56%. Operating margin FY2025 -174.65%. Net margin FY2023 45.40%. Net margin FY2024 -35.42%. Net margin FY2025 -173.85%.

Income trends

Revenue

2.2M USD-34.68%

Operating income

−3.84M USD-220.83%

Net income

−3.82M USD-220.63%
Income trends across reported periods4.08M USD1.2M USD−1.68M USD−4.56M USDRevenue, FY2023: 878.97K USDRevenue, FY2024: 3.36M USDRevenue, FY2025: 2.2M USDOperating income, FY2023: 96.83K USDOperating income, FY2024: −1.2M USDOperating income, FY2025: −3.84M USDNet income, FY2023: 399.04K USDNet income, FY2024: −1.19M USDNet income, FY2025: −3.82M USDFY2023FY2024FY2025
Revenue FY2023 878.97K USD. Revenue FY2024 3.36M USD. Revenue FY2025 2.2M USD. Operating income FY2023 96.83K USD. Operating income FY2024 −1.2M USD. Operating income FY2025 −3.84M USD. Net income FY2023 399.04K USD. Net income FY2024 −1.19M USD. Net income FY2025 −3.82M USD.
Metric (USD)FY2025FY2024FY2023
Revenue2.2M USD3.36M USD878.97K USD
Cost of goods sold1.42M USD1.43M USD140.96K USD
Gross profit775.06K USD1.93M USD738.01K USD
Research and development2.07M USD2.02M USD—
Selling, general, and administrative2.54M USD1.11M USD641.18K USD
Operating expenses4.61M USD3.13M USD641.18K USD
Interest income40.3K USD45.3K USD1.61K USD
Depreciation and amortization93.69K USD47.25K USD37.19K USD
Operating income−3.84M USD−1.2M USD96.83K USD
Net income−3.82M USD−1.19M USD399.04K USD

Company facts updated Aug 24, 2026.

SLBT peers

Amgen Inc. logo

AMGN

Amgen Inc.

$439.33

+1.29%

Gilead Sciences, Inc. logo

GILD

Gilead Sciences, Inc.

$146.12

+1.87%

Vertex Pharmaceuticals Incorporated logo

VRTX

Vertex Pharmaceuticals Incorporated

$548.05

+1.44%

Intuitive Surgical, Inc. logo

ISRG

Intuitive Surgical, Inc.

$378.81

+1.16%

Sanofi logo

SNY

Sanofi

$45.85

+1.55%

Regeneron Pharmaceuticals, Inc. logo

REGN

Regeneron Pharmaceuticals, Inc.

$834.04

+0.90%

Continue in GoAI

Research SLBT

research.disclaimer